There are two non-negotiable beverages in my eyes: coffee and wine. At the end of the work day you will most likely find me firmly attached to the couch with a glass of red and a good book. I have a feeling that the folks over at Treasury Wine Estates (ASX: TWE) are my type
Read More
One of the latest trends in the Australian investing world is the US market. Many Australian investors are flocking to the US to enhance their portfolio performance by either buying broad exposure via Exchange Traded Funds (ETFs) on the Australian market or by finding providers that allow Australian residents to buy and own US shares.
Read More
The world’s most locked down city is finally coming out of lockdown but having spent 3871 days inside under the watchful eyes of Chairman Dan, many Melbournians are stepping out of their homes with a disease not seen in Australia for hundreds of years. While everyone else around the world has been galivanting in daylight,
Read More
Not much compares to the endorphin kick you get after a great gym sesh. Yep, I don’t care what anyone else says, dragging yourself out of bed and into a gym to do endless burpees feels GOOD (when you’re done). Viva Leisure (ASX: VVA) is keen to become the endorphin dealer of choice for Aussies
Read More
Breakthrough clinical trials into new treatments for bone marrow and liver cancer will soon commence after experienced institutional biotech investors with positive track records in companies such as Viralytics, Ophthea and Avita committed $7.2 million towards funding the trials for Pharmaxis (ASX: PXS) and their hero drug PXS-5505. Unlike other cancer treatment drugs on the
Read More
Australia’s booming fintech industry continues to soar on the global stage with regulatory tech company Identitii (ASX: ID8) the latest to see it’s early stage investment in Payble gaining global attention which will secure $1m in service fees on top of their 39.3% equity stake in the startup. The $1m assignment fee will be payable
Read More